Hand Mobility in Scleroderma (HAMIS) test: the reliability of a novel hand function test.

Research output: Contribution to journalArticlepeer-review

77 Citations (SciVal)


Hand Mobility in Scleroderma (HAMIS) is a new hand function test developed for adults who have systemic sclerosis. HAMIS consists of 9 items designed to measure all movements assessed in an ordinary range of motion (ROM)-measured hand test. The aim of this study was to examine the reliability of the test.

Two observers (one occupational therapist and one physiotherapist) performed the assessments independently of each other on 30 adult subjects. There were 25 women and 5 men in the sample (mean age 53 years, average time since diagnosis 4 years). Subjects were tested twice by each rater.

Internal consistency ranged from 0.80 to 0.85 (Cronbach's alpha). Agreement between the two observers was good for all items (estimated kappa 0.52 to 1.00). The agreement between the observers' first and second assessments was moderate to very good for most items (estimated kappa 0.48 to 1.00), but not for the assessment of supination (estimated kappa 0.25 to 0.59).

HAMIS is a reliable instrument for evaluation of hand function on scleroderma patients.
Original languageEnglish
Pages (from-to)369-74
JournalArthritis Care and Research
Issue number6
Publication statusPublished - 2000

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Division of Occupational Therapy (Closed 2012) (013025000)

Subject classification (UKÄ)

  • Occupational Therapy


  • Scleroderma
  • Hand mobility
  • Hand function test
  • Performance index


Dive into the research topics of 'Hand Mobility in Scleroderma (HAMIS) test: the reliability of a novel hand function test.'. Together they form a unique fingerprint.

Cite this